Literature DB >> 21550213

Methylphenidate administration determines enduring changes in neuroglial network in rats.

Carlo Cavaliere1, Giovanni Cirillo, Maria Rosaria Bianco, Walter Adriani, Antonietta De Simone, Damiana Leo, Carla Perrone-Capano, Michele Papa.   

Abstract

Repeated exposure to psychostimulant drugs induces complex molecular and structural modifications in discrete brain regions of the meso-cortico-limbic system. This structural remodeling is thought to underlie neurobehavioral adaptive responses. Administration to adolescent rats of methylphenidate (MPH), commonly used in attention deficit and hyperactivity disorder (ADHD), triggers alterations of reward-based behavior paralleled by persistent and plastic synaptic changes of neuronal and glial markers within key areas of the reward circuits. By immunohistochemistry, we observe a marked increase of glial fibrillary acidic protein (GFAP) and neuronal nitric oxide synthase (nNOS) expression and a down-regulation of glial glutamate transporter GLAST in dorso-lateral and ventro-medial striatum. Using electron microscopy, we find in the prefrontal cortex a significant reduction of the synaptic active zone length, paralleled by an increase of dendritic spines. We demonstrate that in limbic areas the MPH-induced reactive astrocytosis affects the glial glutamatergic uptake system that in turn could determine glutamate receptor sensitization. These processes could be sustained by NO production and synaptic rearrangement and contribute to MPH neuroglial induced rewiring.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550213     DOI: 10.1016/j.euroneuro.2011.04.003

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  12 in total

Review 1.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

2.  Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice.

Authors:  F L Huang; K-P Huang
Journal:  Genes Brain Behav       Date:  2012-08-09       Impact factor: 3.449

3.  Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice.

Authors:  Yudong Gao; Scott A Heldt
Journal:  Behav Neurosci       Date:  2015-02       Impact factor: 1.912

4.  Purinergic Modulation of Spinal Neuroglial Maladaptive Plasticity Following Peripheral Nerve Injury.

Authors:  Giovanni Cirillo; Anna Maria Colangelo; Miluscia Berbenni; Vita Maria Ippolito; Ciro De Luca; Francesco Verdesca; Leonilde Savarese; Lilia Alberghina; Nicola Maggio; Michele Papa
Journal:  Mol Neurobiol       Date:  2014-10-29       Impact factor: 5.590

Review 5.  Synaptic Cytoskeletal Plasticity in the Prefrontal Cortex Following Psychostimulant Exposure.

Authors:  Lauren M DePoy; Shannon L Gourley
Journal:  Traffic       Date:  2015-06-01       Impact factor: 6.215

6.  Methylphenidate Increases Glutamate Uptake in Bergmann Glial Cells.

Authors:  Alain M Guillem; Zila Martínez-Lozada; Luisa C Hernández-Kelly; Esther López-Bayghen; Bruno López-Bayghen; Oscar A Calleros; Marco R Campuzano; Arturo Ortega
Journal:  Neurochem Res       Date:  2015-09-18       Impact factor: 3.996

7.  Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal.

Authors:  Luis A Natividad; Matthew W Buczynski; Loren H Parsons; Oscar V Torres; Laura E O'Dell
Journal:  J Neurochem       Date:  2012-10-01       Impact factor: 5.372

Review 8.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

9.  Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases.

Authors:  B Di Benedetto; R Rupprecht
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

Review 10.  Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.

Authors:  Michael Huss; Wai Chen; Andrea G Ludolph
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.